MLABMESA LABORATORIES INC /CO/vs its industry peers
A metric-by-metric comparison of MESA LABORATORIES INC /CO/ against SIC 3823 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MLAB본 종목 | $710M#5 | 149.3x#5 | 3.8x#4 | 2.8x#2 | 3.4%#5 | 440.0%#1 | 7.4%#5 | 3.6%#5 | 5.8%#5 | 8#1 | 92.2%#2 | 0.5%#4 |
| KEYS | $53.5B#1 | 43.2x#4 | 8.1x#7 | 10.0x#6 | 8.0%#4 | 38.4%#3 | 16.3%#3 | 12.9%#1 | 12.2%#1 | — | 82.8%#3 | — |
| ROP | $38.0B#2 | 16.0x#1 | 2.0x#2 | 4.8x#5 | 12.3%#2 | -0.8%#6 | 28.3%#1 | 8.2%#4 | 6.0%#4 | 6#2 | -23.2%#7 | 0.9%#2 |
| FTV | $17.2B#3 | 33.8x#2 | 2.8x#3 | 4.1x#4 | 1.9%#6 | -36.0%#7 | 17.3%#2 | 8.8%#3 | 6.9%#2 | 5#4 | 16.7%#5 | 0.5%#3 |
| MKSI | $15.6B#4 | 36.8x#3 | 5.2x#6 | 4.0x#3 | 9.6%#3 | 55.3%#2 | 13.4%#4 | 9.9%#2 | 6.8%#3 | 6#2 | 99.5%#1 | 0.4%#5 |
| SENS | $467M#6 | — | 5.2x#5 | 13.3x#7 | 56.9%#1 | 12.1%#4 | -193.8%#7 | -76.5%#7 | -67.4%#6 | 5#4 | -2.4%#6 | — |
| HURC | $147M#7 | — | 0.8x#1 | 0.8x#1 | -4.3%#7 | 9.0%#5 | -5.8%#6 | -7.9%#6 | — | — | 29.3%#4 | 1.4%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3823). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice